Proteomics pp 137-148 | Cite as

LUMIER: A Discovery Tool for Mammalian Protein Interaction Networks

  • Miriam Barrios-RodilesEmail author
  • Jonathan D. Ellis
  • Benjamin J. Blencowe
  • Jeffrey L. Wrana
Part of the Methods in Molecular Biology book series (MIMB, volume 1550)


Protein–protein interactions (PPIs) play an essential role in all biological processes. In vivo, PPIs occur dynamically and depend on extracellular cues. To discover novel protein–protein interactions in mammalian cells, we developed a high-throughput automated technology called LUMIER (LUminescence-based Mammalian IntERactome). In this approach, we co-express a Luciferase (LUC)-tagged fusion protein along with a Flag-tagged protein in an efficiently transfectable cell line such as HEK-293T cells. The interaction between the two proteins is determined by co-immunoprecipitation using an anti-Flag antibody, and the presence of the LUC-tagged interactor in the complex is subsequently detected via its luciferase activity. LUMIER can easily detect transmembrane protein partners, interactions that are signaling- or splice isoform-dependent, as well as those that may occur only in the presence of posttranslational modifications. Using various collections of Flag-tagged proteins, we have generated protein interaction networks for several TGF-β family receptors, Wnt pathway members, and have systematically analyzed the effect of neural-specific alternative splicing on protein interaction networks. The results have provided important insights into the physiological and functional relevance of some of the novel interactions found. LUMIER is highly scalable and can be used for both low- and high-throughput strategies. LUMIER is thus a valuable tool for the identification and characterization of dynamically regulated PPIs in mammalian systems. Here, we describe a manual version of LUMIER in a 96-well format that can be easily implemented in any laboratory.

Key words

Protein–protein interaction LUMIER Mammalian cells Signaling pathways Transmembrane proteins Binary complex Ternary complex 



This work was supported by funding from the Canadian Institutes of Health Research (CIHR) (J.L.W. and B.J.B.), the Alzheimer’s Society of Canada (B.J.B.), and the Krembil Foundation (J.L.W.). We would also like to thank Dr. Saranya Kittanakom for the plasmid schematics framework.


  1. 1.
    Fields S, Song O (1989) A novel genetic system to detect protein-protein interactions. Nature 340(6230):245–246CrossRefPubMedGoogle Scholar
  2. 2.
    Lievens S, Lemmens I, Tavernier J (2009) Mammalian two-hybrids come of age. Trends Biochem Sci 34(11):579–588CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Braun P, Tasan M, Dreze M, Barrios-Rodiles M, Lemmens I, Yu H, Sahalie JM, Murray RR, Roncari L, de Smet AS, Venkatesan K, Rual JF, Vandenhaute J, Cusick ME, Pawson T, Hill DE, Tavernier J, Wrana JL, Roth FP, Vidal M (2009) An experimentally derived confidence score for binary protein-protein interactions. Nat Methods 6(1):91–97CrossRefPubMedGoogle Scholar
  4. 4.
    Eyckerman S, Verhee A, der Heyden JV, Lemmens I, Ostade XV, Vandekerckhove J, Tavernier J (2001) Design and application of a cytokine-receptor-based interaction trap. Nat Cell Biol 3(12):1114–1119CrossRefPubMedGoogle Scholar
  5. 5.
    Stagljar I, Korostensky C, Johnsson N, te Heesen S (1998) A genetic system based on split-ubiquitin for the analysis of interactions between membrane proteins in vivo. Proc Natl Acad Sci U S A 95(9):5187–5192CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Petschnigg J, Groisman B, Kotlyar M, Taipale M, Zheng Y, Kurat CF, Sayad A, Sierra JR, Mattiazzi Usaj M, Snider J, Nachman A, Krykbaeva I, Tsao MS, Moffat J, Pawson T, Lindquist S, Jurisica I, Stagljar I (2014) The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells. Nat Methods 11(5):585–592CrossRefPubMedGoogle Scholar
  7. 7.
    Pelletier JN, Campbell-Valois FX, Michnick SW (1998) Oligomerization domain-directed reassembly of active dihydrofolate reductase from rationally designed fragments. Proc Natl Acad Sci U S A 95(21):12141–12146CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Wilson CG, Magliery TJ, Regan L (2004) Detecting protein-protein interactions with GFP-fragment reassembly. Nat Methods 1(3):255–262CrossRefPubMedGoogle Scholar
  9. 9.
    Remy I, Michnick SW (2006) A highly sensitive protein-protein interaction assay based on Gaussia luciferase. Nat Methods 3(12):977–979CrossRefPubMedGoogle Scholar
  10. 10.
    Boute N, Jockers R, Issad T (2002) The use of resonance energy transfer in high-throughput screening: BRET versus FRET. Trends Pharmacol Sci 23(8):351–354CrossRefPubMedGoogle Scholar
  11. 11.
    Ramachandran N, Hainsworth E, Bhullar B, Eisenstein S, Rosen B, Lau AY, Walter JC, LaBaer J (2004) Self-assembling protein microarrays. Science 305(5680):86–90CrossRefPubMedGoogle Scholar
  12. 12.
    Barrios-Rodiles M, Brown KR, Ozdamar B, Bose R, Liu Z, Donovan RS, Shinjo F, Liu Y, Dembowy J, Taylor IW, Luga V, Przulj N, Robinson M, Suzuki H, Hayashizaki Y, Jurisica I, Wrana JL (2005) High-throughput mapping of a dynamic signaling network in mammalian cells. Science 307(5715):1621–1625CrossRefPubMedGoogle Scholar
  13. 13.
    Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL (2005) Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 307(5715):1603–1609CrossRefPubMedGoogle Scholar
  14. 14.
    Miller BW, Lau G, Grouios C, Mollica E, Barrios-Rodiles M, Liu Y, Datti A, Morris Q, Wrana JL, Attisano L (2009) Application of an integrated physical and functional screening approach to identify inhibitors of the Wnt pathway. Mol Syst Biol 5:315CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Hall MP, Unch J, Binkowski BF, Valley MP, Butler BL, Wood MG, Otto P, Zimmerman K, Vidugiris G, Machleidt T, Robers MB, Benink HA, Eggers CT, Slater MR, Meisenheimer PL, Klaubert DH, Fan F, Encell LP, Wood KV (2012) Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate. ACS Chem Biol 7(11):1848–1857CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Xu G, Barrios-Rodiles M, Jerkic M, Turinsky AL, Nadon R, Vera S, Voulgaraki D, Wrana JL, Toporsian M, Letarte M (2014) Novel protein interactions with endoglin and activin receptor-like kinase 1: potential role in vascular networks. Mol Cell Proteomics 13(2):489–502CrossRefPubMedGoogle Scholar
  17. 17.
    Kittanakom S, Barrios-Rodiles M, Petschnigg J, Arnoldo A, Wong V, Kotlyar M, Heisler LE, Jurisica I, Wrana JL, Nislow C, Stagljar I (2014) CHIP-MYTH: a novel interactive proteomics method for the assessment of agonist-dependent interactions of the human beta(2)-adrenergic receptor. Biochem Biophys Res Commun 445(4):746–756CrossRefPubMedGoogle Scholar
  18. 18.
    Varelas X, Miller BW, Sopko R, Song S, Gregorieff A, Fellouse FA, Sakuma R, Pawson T, Hunziker W, McNeill H, Wrana JL, Attisano L (2010) The Hippo pathway regulates Wnt/beta-catenin signaling. Dev Cell 18(4):579–591CrossRefPubMedGoogle Scholar
  19. 19.
    Beyer TA, Weiss A, Khomchuk Y, Huang K, Ogunjimi AA, Varelas X, Wrana JL (2013) Switch enhancers interpret TGF-beta and Hippo signaling to control cell fate in human embryonic stem cells. Cell Rep 5(6):1611–1624CrossRefPubMedGoogle Scholar
  20. 20.
    Ellis JD, Barrios-Rodiles M, Colak R, Irimia M, Kim T, Calarco JA, Wang X, Pan Q, O’Hanlon D, Kim PM, Wrana JL, Blencowe BJ (2012) Tissue-specific alternative splicing remodels protein-protein interaction networks. Mol Cell 46(6):884–892CrossRefPubMedGoogle Scholar
  21. 21.
    Taipale M, Krykbaeva I, Koeva M, Kayatekin C, Westover KD, Karras GI, Lindquist S (2012) Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. Cell 150(5):987–1001CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Ryzhakov G, Teixeira A, Saliba D, Blazek K, Muta T, Ragoussis J, Udalova IA (2013) Cross-species analysis reveals evolving and conserved features of the nuclear factor kappaB (NF-kappaB) proteins. J Biol Chem 288(16):11546–11554CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Blasche S, Mortl M, Steuber H, Siszler G, Nisa S, Schwarz F, Lavrik I, Gronewold TM, Maskos K, Donnenberg MS, Ullmann D, Uetz P, Kogl M (2013) The E. coli effector protein NleF is a caspase inhibitor. PLoS One 8(3):e58937CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Deng Q, Wang D, Li F (2014) Detection of viral protein-protein interaction by microplate-format luminescence-based mammalian interactome mapping (LUMIER). Virol Sin 29(3):189–192CrossRefPubMedGoogle Scholar
  25. 25.
    Tahoun A, Siszler G, Spears K, McAteer S, Tree J, Paxton E, Gillespie TL, Martinez-Argudo I, Jepson MA, Shaw DJ, Koegl M, Haas J, Gally DL, Mahajan A (2011) Comparative analysis of EspF variants in inhibition of Escherichia coli phagocytosis by macrophages and inhibition of E. coli translocation through human- and bovine-derived M cells. Infect Immun 79(11):4716–4729CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2017

Authors and Affiliations

  • Miriam Barrios-Rodiles
    • 1
    Email author
  • Jonathan D. Ellis
    • 2
  • Benjamin J. Blencowe
    • 2
    • 3
  • Jeffrey L. Wrana
    • 1
    • 3
    • 4
  1. 1.Center for Systems Biology, Lunenfeld-Tanenbaum Research InstituteMount Sinai HospitalTorontoCanada
  2. 2.Donnelly CentreUniversity of TorontoTorontoCanada
  3. 3.Department of Molecular GeneticsUniversity of TorontoTorontoCanada
  4. 4.Breast Cancer ResearchMary Janigan Chair in Molecular Cancer TherapeuticsTorontoCanada

Personalised recommendations